Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Newsoara Hyk Biopharmaceutical (shanghai) Co., Ltd.

Clinical trials sponsored by Newsoara Hyk Biopharmaceutical (shanghai) Co., Ltd., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Virus therapy takes on tough lung cancer Results expected Dec 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

Virus therapy takes on tough lung cancer

Disease control Recruiting now

This study tests a new treatment for advanced small cell lung cancer that has stopped responding to standard therapies. The treatment combines an oncolytic virus (Olvi-Vec) with standard chemotherapy drugs. The goal is to see if this combination is safe and can shrink tumors in 2…

Phase 1/2 • Sponsor: Newsoara HYK Biopharmaceutical (Shanghai) Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 08:00 UTC